{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:25:24Z","timestamp":1792571124991,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K24HL152440"],"award-info":[{"award-number":["K24HL152440"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK089174"],"award-info":[{"award-number":["R01DK089174"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00125-024-06315-0","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T05:40:11Z","timestamp":1731390011000},"page":"357-366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Prediabetes is associated with elevated risk of clinical outcomes even without progression to diabetes"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5607-4848","authenticated-orcid":false,"given":"Mary R.","family":"Rooney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia S.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin B.","family":"Echouffo Tcheugui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4082-4755","authenticated-orcid":false,"given":"Jiaqi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela L.","family":"Lutsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan E.","family":"Grams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Coresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Selvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"6315_CR1","unstructured":"Centers for Disease Control and prevention (2024) National Diabetes Statistics Report. Available from https:\/\/www.cdc.gov\/diabetes\/php\/data-research\/index.html. Accessed 1 September 2024"},{"issue":"6","key":"6315_CR2","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1007\/s00125-023-05890-y","volume":"66","author":"MB Blond","year":"2023","unstructured":"Blond MB, F\u00e6rch K, Herder C, Ziegler D, Stehouwer CDA (2023) The prediabetes conundrum: striking the balance between risk and resources. Diabetologia 66(6):1016\u20131023. https:\/\/doi.org\/10.1007\/s00125-023-05890-y","journal-title":"Diabetologia"},{"issue":"6","key":"6315_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"Diabetes Prevention Program Research Group","year":"2002","unstructured":"Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346(6):393\u2013403. https:\/\/doi.org\/10.1056\/NEJMoa012512","journal-title":"N Engl J Med"},{"issue":"4","key":"6315_CR4","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2337\/diacare.20.4.537","volume":"20","author":"XR Pan","year":"1997","unstructured":"Pan XR, Li GW, Hu YH et al (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20(4):537\u2013544. https:\/\/doi.org\/10.2337\/diacare.20.4.537","journal-title":"Diabetes Care"},{"issue":"12","key":"6315_CR5","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.2337\/diacare.26.12.3230","volume":"26","author":"J Lindstr\u00f6m","year":"2003","unstructured":"Lindstr\u00f6m J, Louheranta A, Mannelin M et al (2003) The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 26(12):3230\u20133236. https:\/\/doi.org\/10.2337\/diacare.26.12.3230","journal-title":"Diabetes Care"},{"issue":"9702","key":"6315_CR6","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","volume":"374","author":"Diabetes Prevention Program Research Group","year":"2009","unstructured":"Diabetes Prevention Program Research Group (2009) 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374(9702):1677\u20131686. https:\/\/doi.org\/10.1016\/S0140-6736(09)61457-4","journal-title":"Lancet"},{"issue":"9733","key":"6315_CR7","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/s0140-6736(10)60484-9","volume":"375","author":"N Sarwar","year":"2010","unstructured":"Sarwar N, Gao P, Seshasai SR et al (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet (London, England) 375(9733):2215\u20132222. https:\/\/doi.org\/10.1016\/s0140-6736(10)60484-9","journal-title":"Lancet (London, England)"},{"issue":"8","key":"6315_CR8","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1111\/dom.14388","volume":"23","author":"X Cai","year":"2021","unstructured":"Cai X, Liu X, Sun L et al (2021) Prediabetes and the risk of heart failure: a meta-analysis. Diabetes Obes Metab 23(8):1746\u20131753. https:\/\/doi.org\/10.1111\/dom.14388","journal-title":"Diabetes Obes Metab"},{"key":"6315_CR9","doi-asserted-by":"publisher","first-page":"m2297","DOI":"10.1136\/bmj.m2297","volume":"370","author":"X Cai","year":"2020","unstructured":"Cai X, Zhang Y, Li M et al (2020) Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis. BMJ (Clinical research ed) 370:m2297. https:\/\/doi.org\/10.1136\/bmj.m2297","journal-title":"BMJ (Clinical research ed)"},{"key":"6315_CR10","doi-asserted-by":"publisher","first-page":"100599","DOI":"10.1016\/j.lanwpc.2022.100599","volume":"30","author":"X Zhang","year":"2023","unstructured":"Zhang X, Wu H, Fan B et al (2023) The role of age on the risk relationship between prediabetes and major morbidities and mortality: analysis of the Hong Kong diabetes surveillance database of 2 million Chinese adults. Lancet Reg Health West Pac 30:100599. https:\/\/doi.org\/10.1016\/j.lanwpc.2022.100599","journal-title":"Lancet Reg Health West Pac"},{"key":"6315_CR11","doi-asserted-by":"publisher","unstructured":"American Diabetes Association\u00a0Professional Practice Committee\u00a0(2024)\u00a03. Prevention or delay of diabetes and associated comorbidities:\u00a0Standards of care in diabetes\u20142024. Diabetes Care 47(Suppl 1):S43\u2013S51. https:\/\/doi.org\/10.2337\/dc24-S003","DOI":"10.2337\/dc24-S003"},{"key":"6315_CR12","doi-asserted-by":"publisher","unstructured":"Chatterton H, Younger T, Fischer A, Khunti K (2012) Risk identification and interventions to prevent type 2 diabetes in adults at high risk: summary of NICE guidance. BMJ (Online) 345(7867). https:\/\/doi.org\/10.1136\/bmj.e4624","DOI":"10.1136\/bmj.e4624"},{"issue":"23","key":"6315_CR13","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1016\/j.jacc.2021.04.035","volume":"77","author":"JD Wright","year":"2021","unstructured":"Wright JD, Folsom AR, Coresh J et al (2021) The ARIC (Atherosclerosis Risk In Communities) study: JACC focus seminar 3\/8. J Am Coll Cardiol 77(23):2939\u20132959. https:\/\/doi.org\/10.1016\/j.jacc.2021.04.035","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"6315_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1753-0407.2010.00070.x","volume":"2","author":"E Selvin","year":"2010","unstructured":"Selvin E, Coresh J, Zhu H, Folsom A, Steffes MW (2010) Measurement of HbA1c from stored whole blood samples in the Atherosclerosis Risk in Communities study. J Diabetes 2(2):118\u2013124. https:\/\/doi.org\/10.1111\/j.1753-0407.2010.00070.x","journal-title":"J Diabetes"},{"issue":"7","key":"6315_CR15","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.2337\/dc09-9033","volume":"32","author":"International Expert Committee","year":"2009","unstructured":"International Expert Committee (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32(7):1327\u20131334. https:\/\/doi.org\/10.2337\/dc09-9033","journal-title":"Diabetes Care"},{"issue":"2","key":"6315_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0895-4356(95)00041-0","volume":"49","author":"AD White","year":"1996","unstructured":"White AD, Folsom AR, Chambless LE et al (1996) Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years\u2019 experience. J Clin Epidemiol 49(2):223\u2013233. https:\/\/doi.org\/10.1016\/0895-4356(95)00041-0","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"6315_CR17","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1161\/01.str.30.4.736","volume":"30","author":"WD Rosamond","year":"1999","unstructured":"Rosamond WD, Folsom AR, Chambless LE et al (1999) Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke J Cereb Circ 30(4):736\u2013743. https:\/\/doi.org\/10.1161\/01.str.30.4.736","journal-title":"Stroke J Cereb Circ"},{"issue":"7","key":"6315_CR18","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.amjcard.2007.11.061","volume":"101","author":"LR Loehr","year":"2008","unstructured":"Loehr LR, Rosamond WD, Chang PP, Folsom AR, Chambless LE (2008) Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). Am J Cardiol 101(7):1016\u20131022. https:\/\/doi.org\/10.1016\/j.amjcard.2007.11.061","journal-title":"Am J Cardiol"},{"issue":"2","key":"6315_CR19","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1161\/circheartfailure.111.963199","volume":"5","author":"WD Rosamond","year":"2012","unstructured":"Rosamond WD, Chang PP, Baggett C et al (2012) Classification of heart failure in the Atherosclerosis Risk in Communities (ARIC) study: a comparison of diagnostic criteria. Circ Heart Fail 5(2):152\u2013159. https:\/\/doi.org\/10.1161\/circheartfailure.111.963199","journal-title":"Circ Heart Fail"},{"issue":"19","key":"6315_CR20","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J et al (2021) New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med 385(19):1737\u20131749. https:\/\/doi.org\/10.1056\/NEJMoa2102953","journal-title":"N Engl J Med"},{"key":"6315_CR21","unstructured":"U.S. Renal Data System (2021) 2021 USRDS annual data report: epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD"},{"issue":"5","key":"6315_CR22","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/ajcn\/36.5.936","volume":"36","author":"JA Baecke","year":"1982","unstructured":"Baecke JA, Burema J, Frijters JE (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36(5):936\u2013942. https:\/\/doi.org\/10.1093\/ajcn\/36.5.936","journal-title":"Am J Clin Nutr"},{"key":"6315_CR23","unstructured":"American Heart Association American Heart Association Recommendations for Physical Activity in Adults and Kids. Available from https:\/\/www.heart.org\/en\/healthy-living\/fitness\/fitness-basics\/aha-recs-for-physical-activity-in-adults. Accessed 7 August 2023"},{"issue":"12","key":"6315_CR24","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.2337\/dc15-1078","volume":"38","author":"SV Eastwood","year":"2015","unstructured":"Eastwood SV, Tillin T, Sattar N, Forouhi NG, Hughes AD, Chaturvedi N (2015) Associations between prediabetes, by three different diagnostic criteria, and incident CVD differ in South Asians and Europeans. Diabetes Care 38(12):2325\u20132332. https:\/\/doi.org\/10.2337\/dc15-1078","journal-title":"Diabetes Care"},{"issue":"2","key":"6315_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00125-021-05592-3","volume":"65","author":"S Schlesinger","year":"2022","unstructured":"Schlesinger S, Neuenschwander M, Barbaresko J et al (2022) Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies. Diabetologia 65(2):275\u2013285. https:\/\/doi.org\/10.1007\/s00125-021-05592-3","journal-title":"Diabetologia"},{"issue":"10","key":"6315_CR26","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.2337\/diacare.26.10.2910","volume":"26","author":"Q Qiao","year":"2003","unstructured":"Qiao Q, Jousilahti P, Eriksson J, Tuomilehto J (2003) Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up. Diabetes Care 26(10):2910\u20132914. https:\/\/doi.org\/10.2337\/diacare.26.10.2910","journal-title":"Diabetes Care"},{"issue":"1","key":"6315_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12933-023-01767-x","volume":"22","author":"J-C Hsu","year":"2023","unstructured":"Hsu J-C, Yang Y-Y, Chuang S-L, Lin L-Y, Chen TH-H (2023) Prediabetes as a risk factor for new-onset atrial fibrillation: the propensity-score matching cohort analyzed using the Cox regression model coupled with the random survival forest. Cardiovasc Diabetol 22(1):35. https:\/\/doi.org\/10.1186\/s12933-023-01767-x","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"6315_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12933-023-01871-y","volume":"22","author":"D Yu","year":"2023","unstructured":"Yu D, Qu B, Osuagwu UL et al (2023) Effect of onset of type 2 diabetes on risks of cardiovascular disease and heart failure among new Zealanders with impaired glucose tolerance over 25 years: tapered-matched landmark analysis. Cardiovasc Diabetol 22(1):163. https:\/\/doi.org\/10.1186\/s12933-023-01871-y","journal-title":"Cardiovasc Diabetol"},{"issue":"14","key":"6315_CR29","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jama.2023.4063","volume":"329","author":"JB Echouffo-Tcheugui","year":"2023","unstructured":"Echouffo-Tcheugui JB, Perreault L, Ji L, Dagogo-Jack S (2023) Diagnosis and management of prediabetes: a review. JAMA 329(14):1206\u20131216. https:\/\/doi.org\/10.1001\/jama.2023.4063","journal-title":"JAMA"},{"issue":"8","key":"6315_CR30","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1001\/jama.2021.12531","volume":"326","author":"US Preventive Services Task Force","year":"2021","unstructured":"US Preventive Services Task Force (2021) Screening for prediabetes and type 2 diabetes: US Preventive Services Task Force recommendation statement. JAMA 326(8):736\u2013743. https:\/\/doi.org\/10.1001\/jama.2021.12531","journal-title":"JAMA"},{"key":"6315_CR31","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee (2024) 10. Cardiovascular disease and risk management: Standards of care in diabetes\u20142024. Diabetes Care 47(Suppl 1):S179\u2013S218. https:\/\/doi.org\/10.2337\/dc24-S010","DOI":"10.2337\/dc24-S010"},{"issue":"1","key":"6315_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/s2213-8587(21)00295-3","volume":"10","author":"P Rossing","year":"2022","unstructured":"Rossing P, Inzucchi SE, Vart P et al (2022) Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials. Lancet Diabetes Endocrinol 10(1):24\u201334. https:\/\/doi.org\/10.1016\/s2213-8587(21)00295-3","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"24","key":"6315_CR33","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1161\/circulationaha.122.059595","volume":"146","author":"N Marx","year":"2022","unstructured":"Marx N, Husain M, Lehrke M, Verma S, Sattar N (2022) GLP-1 receptor agonists for the reduction of atherosclerotic cardiovascular risk in patients with type 2 diabetes. Circulation 146(24):1882\u20131894. https:\/\/doi.org\/10.1161\/circulationaha.122.059595","journal-title":"Circulation"},{"key":"6315_CR34","doi-asserted-by":"publisher","first-page":"100933","DOI":"10.1016\/j.eclinm.2021.100933","volume":"36","author":"R Cardoso","year":"2021","unstructured":"Cardoso R, Graffunder FP, Ternes CMP et al (2021) SGLT2 inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure: a systematic review and meta-analysis. EClinicalMedicine 36:100933. https:\/\/doi.org\/10.1016\/j.eclinm.2021.100933","journal-title":"EClinicalMedicine"},{"issue":"24","key":"6315_CR35","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","volume":"389","author":"AM Lincoff","year":"2023","unstructured":"Lincoff AM, Brown-Frandsen K, Colhoun HM et al (2023) Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med 389(24):2221\u20132232. https:\/\/doi.org\/10.1056\/NEJMoa2307563","journal-title":"N Engl J Med"},{"issue":"1","key":"6315_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/s2213-8587(16)30321-7","volume":"5","author":"B Warren","year":"2017","unstructured":"Warren B, Pankow JS, Matsushita K et al (2017) Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol 5(1):34\u201342. https:\/\/doi.org\/10.1016\/s2213-8587(16)30321-7","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6315_CR37","doi-asserted-by":"publisher","first-page":"215013272110165","DOI":"10.1177\/21501327211016579","volume":"12","author":"ES Banerjee","year":"2021","unstructured":"Banerjee ES, Shaak K, Burgess N, Johnson M, Careyva B (2021) Factors associated with clinician adherence to USPSTF diabetes screening recommendations. J Prim Care Community Health 12:21501327211016580. https:\/\/doi.org\/10.1177\/21501327211016579","journal-title":"J Prim Care Community Health"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-024-06315-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-024-06315-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-024-06315-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:03:14Z","timestamp":1762902194000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-024-06315-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,12]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["6315"],"URL":"https:\/\/doi.org\/10.1007\/s00125-024-06315-0","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,12]]},"assertion":[{"value":"28 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors thank the staff and participants of the ARIC study for their important contributions. Parts of this study were presented as an abstract at the American Diabetes Association Scientific Sessions, 23\u201326 June 2023.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Acknowledgements"}},{"value":"The datasets analysed within this study are not publicly available due to the possibility that some information in these data might compromise research participants\u2019 privacy or consent. However, data may be available from the corresponding author on reasonable request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The Atherosclerosis Risk in Communities study has been funded in whole or in part with Federal funds from the National Heart, Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services, under contract numbers 75N92022D00001, 75N92022D00002, 75N92022D00003, 75N92022D00004 and 75N92022D00005. Research reported in this publication was supported by the NIH\/NIDDK grant R01DK089174 (to ES) and NIH\/NHLBI grant K24HL152440 (to ES). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Some of the data reported here have been supplied by the United States Renal Data System. The interpretation and reporting of these data are the responsibility of the authors and in no way should be seen as an official policy or interpretation of the US Government.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"ES is a member of the Editorial Board of Diabetologia but was not involved in any of the decisions regarding review of this manuscript or its acceptance. The authors declare that there are no other relationships or activities that might bias, or be perceived to bias, their work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 relationships and activities"}},{"value":"MRR and ES were involved in the conception, design and conduct of the study. MRR wrote the first draft of the manuscript. MRR, JBET, ASW, MF, JH and PLL were involved in the analysis and interpretation of the results. ES, MEG and JC were involved in the acquisition of data. All authors edited, reviewed and approved the final version of the manuscript. MRR is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}